Welltower upsizes pricing of $900 million of exchangeable senior notes
By
Kathleen Steele Gaivin
Jul 10, 2024
Just a day after announcing a $750 million debt offering, Welltower’s operating company, Welltower OP, upsized the offering to $900 million in 3.125% exchangeable senior notes due in 2029, the Toledo,...
People with opioid use disorder less likely to receive palliative care
Apr 29, 2024
The difference did not persist after exclusion of people who died suddenly.
2020 to 2022 saw increase in enrollment in medical cannabis programs
Apr 08, 2024
The proportion of patient-reported qualifying conditions with substantial, conclusive evidence of therapeutic value decreased.
FDA says yogurt makers can make ‘qualified’ claims about T2D prevention
Mar 04, 2024
A “qualified health claim” does not meet the more rigorous “significant scientific agreement” standard
.
Considerable variation seen in mortality rates for suspected sepsis
May 28, 2024
A 30-fold variation was seen in crude deaths depending on the site of infection, and a 13-fold variation was seen across organ dysfunctions.
Arizona AL community turns over control to third party amid abuse, fraud allegations
By
Kimberly Bonvissuto
Apr 26, 2024
An Arizona assisted living owner has turned over control of its community to a third-party receiver following allegations of elder abuse and consumer fraud.
Antihypertensives linked to eczematous dermatitis in seniors
May 24, 2024
The largest effect sizes were seen for diuretics and calcium channel blockers, and the smallest were seen for ACE inhibitors and beta-blockers.
Genital talc use positively linked to ovarian cancer
May 21, 2024
Frequent douching and douching during young adulthood also was positively associated with ovarian cancer.
New stroke risk down with clopidogrel-aspirin initiated within 72 hours
Dec 28, 2023
The findings were seen among patients with mild ischemic stroke or high-risk transient ischemic attack of presumed atherosclerotic cause.
Suicidal ideation, behaviors not increased with GLP-1 RAs for seniors with T2D
Jul 16, 2024
No significant increase was seen with the use of GLP-1 RAs versus SGLT2is or DPP4is among older Medicare beneficiaries.